Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Page 1
European and United Kingdom COVID-19 pandemic experience: The same but different.
Carroll WD, Strenger V, Eber E, Porcaro F, Cutrera R, Fitzgerald DA, Balfour-Lynn IM. Carroll WD, et al. Among authors: balfour lynn im. Paediatr Respir Rev. 2020 Sep;35:50-56. doi: 10.1016/j.prrv.2020.06.012. Epub 2020 Jul 4. Paediatr Respir Rev. 2020. PMID: 32709461 Free PMC article. Review.
Initiating Self-Administration of Medicines for inpatients with cystic fibrosis.
Balfour-Lynn IM, Khan K, Pentayya N, Pheasant C, Bentley S, Makhecha S. Balfour-Lynn IM, et al. Arch Dis Child. 2020 Oct;105(10):986-990. doi: 10.1136/archdischild-2019-318368. Epub 2020 Apr 7. Arch Dis Child. 2020. PMID: 32265189
The SAM scheme is applicable to all children with chronic disease on long term medications when they are in hospital....
The SAM scheme is applicable to all children with chronic disease on long term medications when they are in hospital....
Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one year.
Davies G, Thia LP, Stocks J, Bush A, Hoo AF, Wade A, Nguyen TTD, Brody AS, Calder A, Klein NJ, Carr SB, Wallis C, Suri R, Pao CS, Ruiz G, Balfour-Lynn IM; London Cystic Fibrosis Collaboration (LCFC). Davies G, et al. Among authors: balfour lynn im. J Cyst Fibros. 2020 Nov;19(6):896-901. doi: 10.1016/j.jcf.2020.01.006. Epub 2020 Feb 7. J Cyst Fibros. 2020. PMID: 32044244 Free article.
CONCLUSIONS: In this UK NBS cohort at one year of age, lung and airway damage is much milder and associations between inflammation, abnormal physiology and structural changes were at best weak, contrary to our hypothesis and previously published reports. Continued follow-up will …
CONCLUSIONS: In this UK NBS cohort at one year of age, lung and airway damage is much milder and associations between inflammation, abnormal …
Inhaled corticosteroids for cystic fibrosis.
Balfour-Lynn IM, Welch K, Smith S. Balfour-Lynn IM, et al. Cochrane Database Syst Rev. 2019 Jul 4;7(7):CD001915. doi: 10.1002/14651858.CD001915.pub6. Cochrane Database Syst Rev. 2019. PMID: 31271656 Free PMC article.
There is some evidence they may cause harm in terms of growth. It has not been established whether long-term use is beneficial in reducing lung inflammation, which should improve survival, but it is unlikely this will be proven conclusively in a randomised controlled trial …
There is some evidence they may cause harm in terms of growth. It has not been established whether long-term use is beneficial in red …
Habit-tic cough: Presentation and outcome with simple reassurance.
Wright MFA, Balfour-Lynn IM. Wright MFA, et al. Among authors: balfour lynn im. Pediatr Pulmonol. 2018 Apr;53(4):512-516. doi: 10.1002/ppul.23948. Epub 2018 Jan 24. Pediatr Pulmonol. 2018. PMID: 29363880
CONCLUSIONS: Habit cough can be diagnosed from the characteristic history; the crucial question is whether the cough disappears during sleep. We have shown successful long term outcomes following a single consultation with simple reassurance, but it is important that the c …
CONCLUSIONS: Habit cough can be diagnosed from the characteristic history; the crucial question is whether the cough disappears during sleep …
Inhaled corticosteroids for cystic fibrosis.
Balfour-Lynn IM, Welch K. Balfour-Lynn IM, et al. Cochrane Database Syst Rev. 2016 Aug 23;(8):CD001915. doi: 10.1002/14651858.CD001915.pub5. Cochrane Database Syst Rev. 2016. PMID: 27552284 Free article. Updated. Review.
There is some evidence they may cause harm in terms of growth. It has not been established whether long-term use is beneficial in reducing lung inflammation, which should improve survival, but it is unlikely this will be proven conclusively in a randomised controlled trial …
There is some evidence they may cause harm in terms of growth. It has not been established whether long-term use is beneficial in red …
Inhaled corticosteroids for cystic fibrosis.
Balfour-Lynn IM, Welch K. Balfour-Lynn IM, et al. Cochrane Database Syst Rev. 2014 Oct 9;(10):CD001915. doi: 10.1002/14651858.CD001915.pub4. Cochrane Database Syst Rev. 2014. PMID: 25300165 Updated. Review.
There is some evidence they may cause harm in terms of growth. It has not been established whether long-term use is beneficial in reducing lung inflammation, which should improve survival, but it is unlikely this will be proven conclusively in a randomised controlled trial …
There is some evidence they may cause harm in terms of growth. It has not been established whether long-term use is beneficial in red …
Personalised medicine in cystic fibrosis is unaffordable.
Balfour-Lynn IM. Balfour-Lynn IM. Paediatr Respir Rev. 2014 Jun;15 Suppl 1:2-5. doi: 10.1016/j.prrv.2014.04.003. Epub 2014 Apr 13. Paediatr Respir Rev. 2014. PMID: 24832698 Review.
However the cost of personalised medicine is too high, making it unaffordable in the long term for many healthcare systems. Society needs to find a way to make personalised medicine affordable in order to not deny life-changing treatments from patients....
However the cost of personalised medicine is too high, making it unaffordable in the long term for many healthcare systems. Society n …
Inhaled corticosteroids for cystic fibrosis.
Balfour-Lynn IM, Welch K. Balfour-Lynn IM, et al. Cochrane Database Syst Rev. 2012 Nov 14;11:CD001915. doi: 10.1002/14651858.CD001915.pub3. Cochrane Database Syst Rev. 2012. PMID: 23152209 Updated. Review.
There is some evidence they may cause harm in terms of growth. It has not been established whether long-term use is beneficial in reducing lung inflammation, which should improve survival, but it is unlikely this will be proven conclusively in a randomised controlled trial …
There is some evidence they may cause harm in terms of growth. It has not been established whether long-term use is beneficial in red …
Long-term effectiveness of a staged assessment for paediatric problematic severe asthma.
Sharples J, Gupta A, Fleming L, Bossley CJ, Bracken-King M, Hall P, Hayward A, Puckey M, Balfour-Lynn IM, Rosenthal M, Bush A, Saglani S. Sharples J, et al. Among authors: balfour lynn im. Eur Respir J. 2012 Jul;40(1):264-7. doi: 10.1183/09031936.00209511. Eur Respir J. 2012. PMID: 22753835 Free PMC article. No abstract available.
17 results